# LAMOTRIGINE
> **ANDA211821** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-10-01
## Drug
- **FDA Application Number:** ANDA211821
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMOTRIGINE
- **Generic name:** LAMOTRIGINE
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2024-10-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211821)
---
*MORVS · CC0 1.0*